Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Godrej Consumer Products reported a tough Q3 FY25 with consolidated organic revenue growth of 6% but flat volumes and a 10% decline in reported EBITDA.
✓ Verified against BSE filing
Godrej Consumer Products reported a tough Q3 FY25 with consolidated organic revenue growth of 6% but flat volumes and a 10% decline in reported EBITDA. India business was particularly weak, with flat volumes, 4% revenue growth, and 21% EBITDA decline, driven by macro slowdown, high palm oil prices causing destocking, and a poor household insecticide season. Management maintained advertising spend at ~10% and consolidated EBITDA margin at ~20%. International businesses performed better, with Indonesia growing 9% revenue and 12% EBITDA, and Latin America seeing >25% volume growth. Management expects sequential improvement in volume and value growth by Q4 FY25 and margin recovery by H1 FY26. Key risks include sustained urban consumption weakness and high PFAD prices delaying margin normalization.
गोधरेज कंज्यूमर प्रोडक्ट्स की तीसरी तिमाही (अक्टूबर-दिसंबर 2024) मुश्किल रही। कंपनी की कमाई 6% बढ़ी, लेकिन बिक्री की मात्रा (वॉल्यूम) स्थिर रही और मुनाफा (EBITDA) 10% गिर गया। भारत में कारोबार कमजोर रहा - वॉल्यूम नहीं बढ़ा, कमाई सिर्फ 4% बढ़ी और मुनाफा 21% गिरा। इसकी वजहें थीं: अर्थव्यवस्था में सुस्ती, पाम तेल के ऊंचे दामों के कारण डीलरों ने स्टॉक कम किया, और कीटनाशकों की बिक्री का मौसम खराब रहा। कंपनी ने विज्ञापन पर खर्च जारी रखा और मुनाफा मार्जिन 20% रहा। विदेशों में हालात बेहतर थे - इंडोनेशिया में कमाई 9% और मुनाफा 12% बढ़ा, लैटिन अमेरिका में वॉल्यूम 25% से ज्यादा बढ़ा। कंपनी को उम्मीद है कि मार्च 2025 तिमाही में वॉल्यूम और कमाई में सुधार होगा, और अगले साल की पहली छमाही तक मुनाफा सामान्य हो जाएगा। जोखिम: शहरी खपत कमजोर रह सकती है और पाम तेल के ऊंचे दाम मुनाफा सुधार में देरी कर सकते हैं।
0 delivered, 0 close, 2 missed.
View Promises →Urban consumption slowdown
View Risks →Full transcript text is available on this route.
Read Transcript →India business volume growth was flat in Q3 FY25, impacted by destocking and poor HI season.
Indonesia continued solid performance with 6% volume growth and 9% revenue growth.
Latin America delivered volume growth greater than 25% with EBITDA margins in double digits.
Incense sticks market share reached high single digits overall, with 50% share among handlers.
Management expects volume and value growth to improve sequentially in Q4 FY25, with a return to H1-like levels by Q1 FY26.
Management targets India EBITDA margins in the 24-26% range, expecting to reach this level in the next 6-8 months.
Management expects Africa business to report positive organic revenue growth by Q4 FY25.
Management indicated need for one or two more rounds of pricing in soaps to restore normative margins.
Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investments.
The Raymond consumer portfolio EBITDA may be slightly below the promised 145-150 crore for the year due to distribution missteps in urban general trade.
Management targets high single-digit volume growth for household insecticides, driven by RNF molecule rollout and distribution expansion.
Africa EBITDA margins are expected to reach high teens, driven by supply chain efficiencies and stable macro conditions.
Despite palm oil correction, PFAD prices remain high, delaying margin normalization in soaps. Management expects margins to remain similar in Q4.
Only 40-50% of offtakes in liquid vaporizers are RNF, with old product still in pipeline. Full transition may take longer.
Competitors like Rin have lowered prices in liquid detergents, potentially challenging Fab's growth trajectory.
Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.
Raymond consumer portfolio may miss the 145-150 crore EBITDA target due to distribution issues in urban GT, though management expects only a slight shortfall.
Market leader's adoption of bathing bar technology could widen price gap, though management believes quality focus will protect market share.
Mentioned in Q2 FY24, Q3 FY24
Management anticipates steady improvement in EBITDA margins through structural cost reduction actions.
Management expects volume and value growth to improve sequentially in Q4 FY25, with a return to H1-like levels by Q1 FY26.
Management noted a significant urban slowdown, with premium products and modern trade under pressure, which could persist and impact growth.
View Risks →